Tuesday, April 20, 2021

FDA overdue on guidance as DSCSA deadline looms - RAPS.org

According to the article:

"Legal experts advised the pharmaceutical industry to start preparing now to meet the November 2023 deadline for having fully electronic interoperable systems in place for tracking  products through the supply chain under the Drug Supply Chain Security Act (DSCSA).

Food and drug law attorneys outlined ways the industry can meet these requirements at a 15 April traceability forum on DSCSA implementation sponsored by the Healthcare Distributors Association (HDA)."

Read the full source article:  FDA overdue on guidance as DSCSA deadline looms - RAPS.org

You might also be interested in:  Drug Supply Chain Security Act Law and Policies - FDA.gov

Return to SkillsPlus International Info Blog - Home

SkillsPlus Intl Inc. - The Best GMP Training & cGMP Training Around
Free GMP Training Tips
Root Cause Analysis - GMP Training
Deviation Investigation Report Writing - GMP Training
Qualstar Simulation - Advanced GMP Training That's Fun!

 

Thursday, April 15, 2021

Remote Interactive Evaluations of Drug Manufacturing and Bioresearch Monitoring Facilities During the COVID-19 Public Health Emergency | Guidance for Industry - FDA.gov

According to the guidance document:

"FDA plays a critical role in protecting the United States from threats such as emerging infectious diseases, including the Coronavirus Disease 2019 (COVID-19) pandemic. FDA is committed to providing timely guidance to support response efforts to this pandemic.

FDA is issuing this guidance to describe how we will request and conduct voluntary remote interactive evaluations at facilities where drugs are manufactured, processed, packed, or held; facilities covered under FDA's bioresearch monitoring (BIMO) program; and outsourcing facilities registered under section 503B of the Federal Food, Drug, and Cosmetic Act (FD&C Act) for the duration of the COVID-19 public health emergency.

This policy is intended to remain in effect only for the duration of the public health emergency related to COVID-19 declared by the Secretary of Health and Human Services (HHS) on January 31, 2020, effective January 27, 2020, including any renewals made by the HHS Secretary in accordance with section 319(a)(2) of the Public Health Service Act (PHS Act) (42 U.S.C. 247d(a)(2))."

View the full source document: Remote Interactive Evaluations of Drug Manufacturing and Bioresearch Monitoring Facilities During the COVID-19 Public Health Emergency Guidance for Industry - FDA.gov (PDF)

Return to SkillsPlus International Info Blog - Home

SkillsPlus Intl Inc. - The Best GMP Training & cGMP Training Around
Free GMP Training Tips
Root Cause Analysis - GMP Training
Deviation Investigation Report Writing - GMP Training
Qualstar Simulation - Advanced GMP Training That's Fun!

 

Thursday, April 1, 2021

California Designated Representative 3PL Course

SkillsPlus International Inc. is the ONLY Board-approved provider of all three of the following online training programs.

California Designated Representative-3PL Training Course

If you are applying for a California Designated Representative 3PL license, then you’re also going to need to include proof of required training (specifically, a training affidavit) in your California Designated Representative-3PL license application packet. Earn a training affidavit by taking any of our California Designated Representative training courses.

About this online training course:

  • Price: $525 per student
  • Enter our online classroom to take the course. Available 24 x 7.
  • This course is approved by the California State Board of Pharmacy.
  • The course covers all required topics specified in the Board's license application.
  • Successful course completion earns a training affidavit accepted by the Board, to include in your California Designated Representative 3PL license application.
  • Sign-Up Now! California Designated Representative 3PL online training course

 

California Designated Representative-3PL Training Course. Image of a glowing blue laptop against a dark background.
Register for this class, California Designated Representative-3PL Training Course.
Earns a training affidavit accepted by the California Board of Pharmacy.